Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Use of 18F-Fluciclovine PET for Discerning Tumor From Treatment Change in Patients With Brain Metastases Undergoing Immunotherapy

NCT06159335 is registered in ClinicalTrials.gov with University of Wisconsin, Madison as lead sponsor.

NCT NCT06159335
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06159335 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Use of 18F-Fluciclovine PET for Discerning Tumor From Treatment Change in Patients With Brain Metastases Undergoing Immunotherapy
Lead sponsor
University of Wisconsin, Madison
Phase
Phase 3
Overall status
Recruiting
Start date
January 10, 2024
Completion date
June 30, 2027
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

brain metastasis, immunotherapy, active, radiation therapy